Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06281977 · ClinicalTrials.gov registry record · Phase 3
Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm
A Phase 3 study, sponsored by Ottawa Heart Institute Research Corporation.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 192
- Enrollment target
NCT06281977 is a Phase 3 study that is actively recruiting participants, run by Ottawa Heart Institute Research Corporation. The registered enrollment target is 192 participants.
The verdict
NCT06281977, a Phase 3 study, is actively recruiting participants, sponsored by Ottawa Heart Institute Research Corporation.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 192 participants
- Enrollment target
Study Summary
The objective of this study is to determine if there is a meaningful benefit to using the sedative medication dexmedetomidine in the acute treatment of patients with recurrent ventricular arrhythmias, known as electrical storm. This will be a multi-centre, double-blinded, placebo-controlled, randomized trial. Patients with electrical storm will be randomized to receive 48 to 72 hours of dexmedetomidine or placebo as part of their initial treatment in an intensive care unit.
Interventions
- DRUG Normal saline
- DRUG Dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2024-05-08 |
| Est. Completion | 2027-08-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06281977
The ClinicalTrials.gov registry entry for NCT06281977 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 192 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ottawa Heart Institute Research Corporation, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal saline is the first listed.
NCT06281977 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06281977 about?
NCT06281977 is a clinical study titled "Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm". The objective of this study is to determine if there is a meaningful benefit to using the sedative medication dexmedetomidine in the acute treatment of patients with recurrent ventricular arrhythmias, known as electrical storm. This will be a multi-centre, double-blinded, placebo-controlled, randomi...
What is the current status of trial NCT06281977?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 192 participants. The study started on 2024-05-08. Estimated completion is 2027-08-01.
What interventions are being tested in trial NCT06281977?
The interventions under investigation include: Normal saline (DRUG), Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT06281977?
This trial is sponsored by Ottawa Heart Institute Research Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.